Finch Therapeutics Group, Inc. Common Stock (FNCH)

Etorro trading 970x250

About Finch Therapeutics Group, Inc. Common Stock

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, engages in developing a novel class of orally administered biological drugs in the United States. The company’s lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the treatment of patients with recurrent Clostridioides difficile infection. It is also developing CP101 for the treatment of chronic hepatitis B virus; FIN-211, an orally administered enriched consortia product candidate that is in clinical development for use in the treatment of autism spectrum disorder; and FIN-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and crohn’s disease. The company has collaborations and license agreements with Millennium Pharmaceuticals, Inc.; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Address: 200 Inner Belt Road, Somerville, MA, United States, 02143

Finch Therapeutics Group, Inc. Common Stock News and around…

Latest news about Finch Therapeutics Group, Inc. Common Stock (FNCH) common stock and company :

What Type Of Shareholders Make Up Finch Therapeutics Group, Inc.'s (NASDAQ:FNCH) Share Registry?
18 Oct, 2021 Yahoo! Finance

The big shareholder groups in Finch Therapeutics Group, Inc. ( NASDAQ:FNCH ) have power over the company. Insiders...

Finch Therapeutics to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit
12 Oct, 2021 Yahoo! Finance

SOMERVILLE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today announced that Mark Smith, PhD, Chief Executive Officer, will present at the Jefferies Virtual Next Generation IBD Therapeutics Summit on Tuesday, October 19, 2021. The pre-recorded presentation wil

Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors
05 Oct, 2021 Yahoo! Finance

SOMERVILLE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today announced that Samuel Allen (Al) Hamood has joined Finch’s Board of Directors. Mr. Hamood is an accomplished executive with over 30 years of experience in finance, business development, corporate st

Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
08 Sep, 2021 FinancialContent
Finch Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep, 2021 FinancialContent
Insiders might want to re-evaluate their US$42m stock purchase as Finch Therapeutics Group, Inc. (NASDAQ:FNCH) drops to US$606m
18 Aug, 2021 Yahoo! Finance

The recent price decline of 8.7% in Finch Therapeutics Group, Inc.'s ( NASDAQ:FNCH ) stock may have disappointed...

Takeda To Lead Finch-Partnered Microbiome IBD Drug
10 Aug, 2021 FinancialContent

Finch Therapeutics Group Inc(NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) haselected to ...

Finch Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
10 Aug, 2021 FinancialContent
Finch Therapeutics Announces Takeda to Accelerate Leadership Role in FIN-524 Ulcerative Colitis Development Program
10 Aug, 2021 FinancialContent
61 Biggest Movers From Yesterday
23 Jul, 2021 FinancialContent

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company ...

38 Stocks Moving In Thursday's Mid-Day Session
22 Jul, 2021 FinancialContent

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from ...

12 Health Care Stocks Moving In Thursday's Intraday Session
22 Jul, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As ...

Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes
28 Jun, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's Intraday Session
25 Jun, 2021 FinancialContent

Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) stock increased by 39.78% to $3.97 during Friday's regular session. ...

Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
28 May, 2021 FinancialContent
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
13 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates
13 May, 2021 FinancialContent
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
12 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
11 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
06 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
06 May, 2021 FinancialContent
Biotech companies are trying to solve stubborn illnesses using ‘drugs from bugs’
30 Apr, 2021 FinancialContent

The body's so-called germ squad in the gut can be tweaked, treating diseases including autism and Parkinson's disease.

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
28 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Finch Therapeutics Appoints Susan E. Graf to Board of Directors
27 Apr, 2021 FinancialContent
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
22 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
21 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit
15 Apr, 2021 FinancialContent
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021
13 Apr, 2021 FinancialContent

Upgrades For Booking Holdings Inc (NASDAQ:BKNG), Jefferies upgraded the previous rating of Hold to Buy. In the fourth ...

The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
10 Apr, 2021 FinancialContent

Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a ...

Finch Therapeutics Group, Inc. Common Stock (FNCH) is a NASDAQ Common Stock listed in , ,

970x250